Year 2019 / Volume 111 / Number 2
Case Report
Apixaban-induced liver injury

161-163

DOI: 10.17235/reed.2018.5877/2018

Salvador Machlab, Mireia Miquel, Mercedes Vergara, María Rosa Escoda, Meritxell Casas,

Abstract
The use of new oral anticoagulants such as apixaban is increasing. We present the case of an 85-year-old patient who was diagnosed with mixed profile toxic hepatitis due to apixaban use. An etiological study was negative, except for anti-smooth muscle antibodies, and a liver biopsy ruled out autoimmune hepatitis. The patient was assigned a score of 7 on the CIOMS/RUCAM scale, indicating a probable causality. The liver injury improved after the withdrawal of apixaban. A previous meta-analysis reported that the risk of hepatotoxicity does not increase with the use of apixaban, nor were any cases reported in registry studies. Nonetheless, more than 120 possible cases currently appear in the European pharmacovigilance database (EudraVigilance). We suggest that apixaban should be considered as a possible cause of liver injury.
Share Button
New comment
Comments
No comments for this article
References
1. Frost C, Nepal S, Wang J, et al. Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects. British Journal of Clinical Pharmacology 2013; 76:776–786.
2. Eudravigilance. [Internet] [Consultado Agosto 2018] Available from: http://www.adrreports.eu/
3. DeLeve LD, Kaplowitz N. Mechanisms of drug-induced liver disease. Gastroenterology clinics of North America 1995; 24:787–810.
4. Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. Journal of clinical epidemiology 1993; 46:1323–30.
5. Intagliata NM, Henry ZH, Maitland H, et al. Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation. Digestive Diseases and Sciences 2016; 61:1721–1727.
6. Caldeira D, Barra M, Santos AT, et al. Risk of drug-induced liver injury with the new oral anticoagulants: Systematic review and meta-analysis. Heart 2014; 100:550–556.
7. Cordeanu M, Lambert A, Gaertner S, et al. Apixaban-induced hepatotoxicity. International Journal of Cardiology 2016; 204:4–5.
8. Alonso A, MacLehose RF, Chen LY, et al. Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation. Heart 2017; 103:834–839.
Related articles

Editorial

Hemophilia and hepatology, back to the future

DOI: 10.17235/reed.2024.10105/2023

Letter

Mixed adenoneuroendocrine carcinoma of the gallbladder

DOI: 10.17235/reed.2023.9624/2023

Letter

Cefditoren-induced hepatitis

DOI: 10.17235/reed.2022.8801/2022

Letter

Curcumin and curcumoids: hepatoprotection or hepatotoxicity?

DOI: 10.17235/reed.2022.8588/2022

Letter

Severe hepatotoxicity secondary to nintedanib

DOI: 10.17235/reed.2020.7585/2020

Letter to the Editor

A case of a mixed adenoneuroendocrine tumor of the colon

DOI: 10.17235/reed.2017.5008/2017

Letter to the Editor

Canalicular cholestasis induced by anabolic steroids

DOI: 10.17235/reed.2017.4781/2016

Citation tools
Machlab S, Miquel M, Vergara M, Escoda M, Casas M. Apixaban-induced liver injury. 5877/2018


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1365 visits.
This article has been downloaded 417 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 20/08/2018

Accepted: 22/09/2018

Online First: 10/12/2018

Published: 01/02/2019

Article revision time: 25 days

Article Online First time: 112 days

Article editing time: 165 days


Share
This article has been rated by 7 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology